Xianglin Zhang

Xianglin Zhang

Auto-generated profile, based on publicly available information

Xianglin Zhang

Department of Clinical Laboratory, The Second Hospital, Cheeloo College of Medicine, Shandong University , Jinan 250033

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2017 in Nature
Verified
Journal Article
Closed access
PDF file
ZDZhenhai Du
Zhenhai Du
HZHui Zheng
Hui Zheng
BHBo Huang
Bo Huang
RMRui Ma
Rui Ma
JWJingyi Wu
Jingyi Wu
WXWei Xie
Wei Xie

17 June 2021 in Genome Research
Verified
Journal Article
Open access
PDF file
XZXianglin Zhang
Xianglin Zhang
XLXuehui Liu
Xuehui Liu
ZDZhenhai Du
Zhenhai Du
LWLei Wei
Lei Wei
HFHuan Fang
Huan Fang
XWXiaowo Wang
Xiaowo Wang
Heterochromatin remodeling is critical for various cell processes. In particular, the “loss of heterochromatin” phenotype in cellular senescence is associated with the process of aging and age-related disorders. Although biological processes of senescent cells, including senescence-associated heterochromatin foci (SAHF) formation, chromosome compaction, and redistribution of key proteins, have been closely associated with high-order chromatin structure, the relationship between the high-order chromatin reorganization and the loss of heterochromatin phenotype during senescence has not been fully understood. By using senescent and deep senescent fibroblasts induced by DNA damage harboring the “loss of heterochromatin” phenotype, we observed progressive 3D reorganization of heterochromatin during senescence. Facultative and constitutive heterochromatin marked by H3K27me3 and H3K9me3, respectively, show different alterations. Facultative heterochromatin tends to switch from the repressive B-compartment to the active A-compartment, whereas constitutive heterochromatin shows no significant changes at the compartment level but enhanced interactions between themselves. Both types of heterochromatin show increased chromatin accessibility and gene expression leakage during senescence. Furthermore, increased chromatin accessibility in potential CTCF binding sites accompanies the establishment of novel loops in constitutive heterochromatin. Finally, we also observed aberrant expression of repetitive elements, including LTR (long terminal repeat) and satellite classes. Overall, facultative and constitutive heterochromatin show both similar and distinct multiscale alterations in the 3D map, chromatin accessibility, and gene expression leakage. This study provides an epigenomic map of heterochromatin reorganization during senescence.

18 February 2025 in Genomics, Proteomics & Bioinformatics
Verified
Journal Article
Open access
WZWei Zhang
Wei Zhang
XZXianglin Zhang
Xianglin Zhang
QLQiao Liu
Qiao Liu
LWLei Wei
Lei Wei
Qiao XuQiao Xu
Qiao Xu
XWXiaowo Wang
Xiaowo Wang
In recent years, computational methods for quantifying cell-type proportions from transcription data have gained significant attention, particularly those reference-based methods which have demonstrated high accuracy. However, there is currently a lack of comprehensive evaluation and guidance for available reference-based deconvolution methods in cell-type deconvolution analysis. In this study, we introduce Deconvolution Evaluator (Deconer), a comprehensive toolkit for the evaluation of reference-based deconvolution methods. Deconer provides various simulated and real gene expression datasets, including both bulk and single-cell sequencing data, and offers multiple visualization interfaces. By utilizing Deconer, we conducted systematic comparisons of 16 reference-based deconvolution methods from different perspectives, including method robustness, accuracy in deconvolving rare components, signature gene selection performance, and external reference construction capability. We also performed an in-depth analysis of the application scenarios and challenges in cell-type deconvolution methods. Finally, we provided constructive suggestions for users to select and develop cell-type deconvolution algorithms. This study provides novel insights for researchers, assisting them in choosing appropriate toolkits, applying solutions in clinical contexts, and advancing the development of deconvolution tools tailored to gene expression data. The tutorials, manual, source code, and demo data of Deconer are publicly available at https://honchkrow.github.io/Deconer/ and https://ngdc.cncb.ac.cn/biocode/tool/7577.

29 May 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
XZXianglin Zhang
Xianglin Zhang
HFHuan Fang
Huan Fang
WZWei Zhang
Wei Zhang
BZBixi Zhong
Bixi Zhong
YLYanda Li
Yanda Li
XWXiaowo Wang
Xiaowo Wang
Background: Recently, liquid biopsy for cancer detection has pursued great progress. However, there are still a lack of high quality markers. It is a challenge to detect cancer stably and accurately in plasma cell free DNA (cfDNA), when the ratio of cancer signal is low. Repetitive genes or elements may improve the robustness of signals. In this study, we focused on ribosomal DNA which repeats hundreds of times in human diploid genome and investigated performances for cancer detection in plasma. Results: We collected bisulfite sequencing samples including normal tissues and 4 cancer types and found that intergenic spacer (IGS) of rDNA has high methylation levels and low variation in normal tissues and plasma. Strikingly, IGS of rDNA shows significant hypo-methylation in tumors compared with normal tissues. Further, we collected plasma bisulfite sequencing data from 224 healthy subjects and cancer patients. Means of AUC in testing set were 0.96 (liver cancer), 0.94 (lung cancer and), 0.92 (colon cancer) with classifiers using only 10 CpG sites. Due to the feature of high copy number, when liver cancer plasma WGBS was down-sampled to 10 million raw reads (0.25× whole genome coverage), the prediction performance decreased only a bit (mean AUC=0.93). Finally, methylation of rDNA could also be used for monitor cancer progression and treatment. Conclusion: Taken together, we provided the high-resolution map of rDNA methylation in tumors and supported that methylation of rDNA was a competitive and robust marker for detecting cancer and monitoring cancer progression in plasma.

25 December 2019
Verified
Journal Article
Closed access
HFHuan Fang
Huan Fang
BZBixi Zhong
Bixi Zhong
LWLei Wei
Lei Wei
XZXianglin Zhang
Xianglin Zhang
WZWei Zhang
Wei Zhang
XWXiaowo Wang
Xiaowo Wang